Urinary incontinence in schizophrenic patients treated with atypical antipsychotics: Urodynamic findings and therapeutic perspectives

International Journal of Psychiatry in Clinical Practice

Volumn 9, Issue 2, 2005, Pages 116-119

  La Torre, Diletta ^a   Isgrò, Sandra ^a   Muscatello, Maria Rosaria Anna ^a,b   Magno, Carlo ^a   Melloni, Darwin ^a   Meduri, Mario ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

Author keywords

Atypical antipsychotics; Etrusor overactivity; Schizophrenia; Urinary incontinence

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CLOZAPINE; OLANZAPINE; RISPERIDONE;

ADULT; BLADDER; BLADDER COMPLIANCE; CLINICAL ARTICLE; CLINICAL FEATURE; DETRUSOR MUSCLE; HUMAN; MALE; OVERACTIVE BLADDER; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; URINE INCONTINENCE; URODYNAMICS;

EID: 21044452879     PISSN: 13651501     EISSN: None     Source Type: Journal    
DOI: 10.1080/13651500510018329     Document Type: Review

References (15)

1. Bonney WW, Gupta S, Hunter DR, Arndt S. Bladder dysfunction in schizophrenia. Schizophrenia Res 1997; 25:243-9.
2. Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology 2003;61(1):37-49.
3. Bogerts B. The neuropathology of schizophrenic diseases: Historical aspects and present knowledge. Eur Arch Psychiatry Clin Neurosci 1999;249(Suppl 4):2-13.
4. Lin CC, Bay YM, Chen JY, Lin CY, Lan TH. A retrospective study of clozapine and urinary incontinence in Chinese in-patients. Acta Psychiatr Scand 1999;100:158-61.
5. Fuller MA, Borovicka MC, Jaskiw GE, Simon MR, Kwon K, Konocki PE. Clozapine-induced urinary incontinence: incidence and treatment with ephedrine. J Clin Psychiatry 1996;57:514-8.
6. Vera PL, Miranda-Sousa A, Nadelhaft I. Effects of two atypical neuroleptics, olanzapine and risperidone, on the function of the urinary bladder and the external urethral sphincter in anesthetized rats. BMC Pharmacology 2001;1:1-4.
7. Hyman MJ, Groutz A, Blaivas JG. Detrusor instability in men: correlation of lower urinary tract symptoms with urodynamic findings. J Urol 2001;166(2):550-2.
8. Kay SR, Fiszbein A, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophren Bull 1987;13:261-76.
9. Warner JP, Harvey CA, Barnes TR. Clozapine and urinary incontinence. Int Clin Psychopharmacol 1994;9:207-9.
10. Murjan S, Doody G, Park B, Tavernor S, Ferguson BG. The prevalence of urinary incontinence in schizophrenia and other severe mental illness. Schizophrenia Res 2003;60(1, Suppl. 15):46-7.
11. Steers WD, Meythaler JM, Haworth C, et al. Effects of acute bolus and chronic continuous intrathecal baclofen on genitourinary dysfunction due to spinal cord pathology. J Urol 1992;148:1849-55.
12. Andersson KE. Treatment of overactive bladder: other drug mechanisms. Urology 2000;55(Suppl 5A):51-7.
13. Kreder K, Mayne C, Jonas U. Long-term safety, tolerability and efficacy of extended-release tolterodine in the treatment of overactive bladder. Eur Urol 2002;41:588-95.
14. Robinson D, Toosz-Hobson P. Detrusor instability. Curr Obstet Gynaecol 2000;11:344-52.
15. Frankenburg FR, Kando JC, Centorrino F, Gilbert JM. Bladder dysfunction associated with clozapine therapy. J Clin Psychiatry 1996;57:39-40.